Dimitris E. Messinis
Pmi R&d
Neuchatel, NE, Switzerland
Neuchatel, NE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Systems biology reveals anatabine to be an NRF2 activator.
Journal: Frontiers in pharmacology
Published: August 03, 2022
MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 21, 2019
A Computational Platform and Guide for Acceleration of Novel Medicines and Personalized Medicine.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 09, 2019
Translational systems pharmacology-based predictive assessment of drug-induced cardiomyopathy.
Journal: CPT: pharmacometrics & systems pharmacology
Published: July 05, 2017
A crowd-sourcing approach for the construction of species-specific cell signaling networks.
Journal: Bioinformatics (Oxford, England)
Published: October 09, 2014
Signaling networks in MS: a systems-based approach to developing new pharmacological therapies.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: August 13, 2014
Network-Based Analysis of Nutraceuticals in Human Hepatocellular Carcinomas Reveals Mechanisms of Chemopreventive Action.
Journal: CPT: pharmacometrics & systems pharmacology
Published: August 04, 2014
Modeling of signaling pathways in chondrocytes based on phosphoproteomic and cytokine release data.
Journal: Osteoarthritis and cartilage
Published: July 29, 2013
Construction of large signaling pathways using an adaptive perturbation approach with phosphoproteomic data.
Journal: Molecular bioSystems
Published: March 27, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026